InvestorsHub Logo

Je3232

03/18/16 7:49 AM

#189578 RE: Couch #189575

Great post on ELTP. Thanks for sharing

NASDAQ2020

05/04/16 8:51 PM

#198225 RE: Couch #189575

In order to be granted a Priority Review, the company seeking the review must show the FDA they have the capability to manufacture and commercialize the approved product.
ELTP $$$

snupoled

05/24/16 9:37 AM

#201570 RE: Couch #189575

thanks Couch,

what a way to begin my day!


we may get earnings call announcement at the end of the week!


Snup

Je3232

05/24/16 11:42 AM

#201585 RE: Couch #189575

Is all of this why the stock only trades at .32. I own a ton and am not seeing any appreciation on my investment. Those that didn't sell at .97 lost a ton and I feel bad for them.

Bngo

07/14/16 12:32 PM

#212253 RE: Couch #189575

I agree with you 100%!
SequestOx ADF will be approved...here is why I am confident of it.
I am asking again for any solid rebuttal out there why the FDA would not approve SequestOx when it has already approved Embeda?

If the FDA has approved Pfizer's Embeda with an ADT labeling, then why wouldn't they approve Elite's SequestOx with similar Abuse Deterrent Technology?

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm419288.



FDA Approves Abuse Deterrent Labeling For EMBEDA® (Morphine Sulfate And Naltrexone Hydrochloride) Extended-Release (ER) Capsules CII

http://www.pfizer.com/news/press-release/press-release-detail/fda_approves_abuse_deterrent_labeling_for_embeda_morphine_sulfate_and_naltrexone_hydrochloride_extended_release_er_capsules_cii

Sixman

07/22/16 12:05 AM

#216464 RE: Couch #189575

I don't believe this post should be stickied anymore. It's content contains inaccurate and dated information.

I ask the moderators to remove the sticky.